C vs OGEN · P/E 16, rev $85.22B vs rev $37.7K
Citigroup Inc. (C) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
C currently screens at market cap $214.73B and trailing P/E 15.5. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the C and OGEN stock pages for the full models.
Not investment advice.